These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 24566866)

  • 21. CSF neurofilament proteins levels are elevated in sporadic Creutzfeldt-Jakob disease.
    van Eijk JJ; van Everbroeck B; Abdo WF; Kremer BP; Verbeek MM
    J Alzheimers Dis; 2010; 21(2):569-76. PubMed ID: 20555148
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic and prognostic value of plasma neurofilament light and total-tau in sporadic Creutzfeldt-Jakob disease.
    Zerr I; Villar-Piqué A; Hermann P; Schmitz M; Varges D; Ferrer I; Riggert J; Zetterberg H; Blennow K; Llorens F
    Alzheimers Res Ther; 2021 Apr; 13(1):86. PubMed ID: 33883011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CSF neurofilament light signature in rapidly progressive neurodegenerative dementias.
    Abu-Rumeileh S; Capellari S; Stanzani-Maserati M; Polischi B; Martinelli P; Caroppo P; Ladogana A; Parchi P
    Alzheimers Res Ther; 2018 Jan; 10(1):3. PubMed ID: 29368621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cerebrospinal fluid tau and amyloid-β1-42 in patients with dementia.
    Skillbäck T; Farahmand BY; Rosén C; Mattsson N; Nägga K; Kilander L; Religa D; Wimo A; Winblad B; Schott JM; Blennow K; Eriksdotter M; Zetterberg H
    Brain; 2015 Sep; 138(Pt 9):2716-31. PubMed ID: 26133663
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cerebrospinal fluid p-tau181, 217, and 231 in definite Creutzfeldt-Jakob disease with and without concomitant pathologies.
    Emeršič A; Ashton NJ; Vrillon A; Lantero-Rodriguez J; Mlakar J; Gregorič Kramberger M; Gonzalez-Ortiz F; Kac PR; Dulewicz M; Hanrieder J; Vanmechelen E; Rot U; Zetterberg H; Karikari TK; Čučnik S; Blennow K
    Alzheimers Dement; 2024 Aug; 20(8):5324-5337. PubMed ID: 38924651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. No added diagnostic value of non-phosphorylated tau fraction (p-tau
    Goossens J; Bjerke M; Struyfs H; Niemantsverdriet E; Somers C; Van den Bossche T; Van Mossevelde S; De Vil B; Sieben A; Martin JJ; Cras P; Goeman J; De Deyn PP; Van Broeckhoven C; van der Zee J; Engelborghs S
    Alzheimers Res Ther; 2017 Jul; 9(1):49. PubMed ID: 28709448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alzheimer's disease cerebrospinal fluid biomarkers differentiate patients with Creutzfeldt-Jakob disease and autoimmune encephalitis.
    Chang BK; Day GS; Graff-Radford J; McKeon A; Flanagan EP; Algeciras-Schimnich A; Mielke MM; Nguyen A; Jones DT; Toledano M; Kremers WK; Knopman DS; Petersen RC; Li W
    Eur J Neurol; 2022 Oct; 29(10):2905-2912. PubMed ID: 35735602
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased CSF transferrin in sCJD: a potential pre-mortem diagnostic test for prion disorders.
    Singh A; Beveridge AJ; Singh N
    PLoS One; 2011 Mar; 6(3):e16804. PubMed ID: 21408069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias.
    Holsinger RM; Lee JS; Boyd A; Masters CL; Collins SJ
    Neurology; 2006 Aug; 67(4):710-2. PubMed ID: 16924032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia.
    Karch A; Llorens F; Schmitz M; Arora AS; Zafar S; Lange P; Schmidt C; Zerr I
    J Alzheimers Dis; 2016 Oct; 54(4):1385-1393. PubMed ID: 27589519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan.
    Satoh K; Shirabe S; Eguchi H; Tsujino A; Eguchi K; Satoh A; Tsujihata M; Niwa M; Katamine S; Kurihara S; Matsuo H
    Cell Mol Neurobiol; 2006 Feb; 26(1):45-52. PubMed ID: 16633900
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cerebrospinal fluid biomarker results in relation to neuropathological dementia diagnoses.
    Brunnström H; Rawshani N; Zetterberg H; Blennow K; Minthon L; Passant U; Englund E
    Alzheimers Dement; 2010 Mar; 6(2):104-9. PubMed ID: 20298970
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.
    Baldeiras IE; Ribeiro MH; Pacheco P; Machado A; Santana I; Cunha L; Oliveira CR
    J Neurol; 2009 Sep; 256(9):1540-50. PubMed ID: 19418113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diagnostic value of surrogate CSF biomarkers for Creutzfeldt-Jakob disease in the era of RT-QuIC.
    Abu-Rumeileh S; Baiardi S; Polischi B; Mammana A; Franceschini A; Green A; Capellari S; Parchi P
    J Neurol; 2019 Dec; 266(12):3136-3143. PubMed ID: 31541342
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cerebrospinal fluid biomarker supported diagnosis of Creutzfeldt-Jakob disease and rapid dementias: a longitudinal multicentre study over 10 years.
    Stoeck K; Sanchez-Juan P; Gawinecka J; Green A; Ladogana A; Pocchiari M; Sanchez-Valle R; Mitrova E; Sklaviadis T; Kulczycki J; Slivarichova D; Saiz A; Calero M; Knight R; Aguzzi A; Laplanche JL; Peoc'h K; Schelzke G; Karch A; van Duijn CM; Zerr I
    Brain; 2012 Oct; 135(Pt 10):3051-61. PubMed ID: 23012332
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sporadic Creutzfeldt-Jakob disease diagnostic accuracy is improved by a new CSF ELISA 14-3-3γ assay.
    Leitão MJ; Baldeiras I; Almeida MR; Ribeiro MH; Santos AC; Ribeiro M; Tomás J; Rocha S; Santana I; Oliveira CR
    Neuroscience; 2016 May; 322():398-407. PubMed ID: 26940479
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cerebrospinal fluid biomarkers in Creutzfeldt-Jakob disease.
    Van Everbroeck B; Boons J; Cras P
    Clin Neurol Neurosurg; 2005 Aug; 107(5):355-60. PubMed ID: 16023527
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creutzfeldt-Jakob disease surveillance in Argentina, 1997-2008.
    Begué C; Martinetto H; Schultz M; Rojas E; Romero C; D'Giano C; Sevlever G; Somoza M; Taratuto AL
    Neuroepidemiology; 2011; 37(3-4):193-202. PubMed ID: 22067221
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CSF neurogranin as a neuronal damage marker in CJD: a comparative study with AD.
    Blennow K; Diaz-Lucena D; Zetterberg H; Villar-Pique A; Karch A; Vidal E; Hermann P; Schmitz M; Ferrer Abizanda I; Zerr I; Llorens F
    J Neurol Neurosurg Psychiatry; 2019 Aug; 90(8):846-853. PubMed ID: 31097472
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.